139 related articles for article (PubMed ID: 35950222)
21. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
22. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
25. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
27. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma.
Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y
Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661
[TBL] [Abstract][Full Text] [Related]
28. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration.
Zhou H; Li S; Lin Y
PeerJ; 2023; 11():e15238. PubMed ID: 37187527
[TBL] [Abstract][Full Text] [Related]
31. Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma.
Zhang X; Fan X; Li X; Wang Y; Zhang Y; Li Y; Zhao J; He D
Front Biosci (Landmark Ed); 2022 Aug; 27(8):252. PubMed ID: 36042187
[TBL] [Abstract][Full Text] [Related]
32. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
33. Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma.
Feng L; Cheng P; Feng Z; Zhang X
World J Surg Oncol; 2022 Feb; 20(1):32. PubMed ID: 35135563
[TBL] [Abstract][Full Text] [Related]
34. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.
Jiang Y; You J; Wu C; Kang Y; Chen F; Chen L; Wu W
J Clin Lab Anal; 2022 Oct; 36(10):e24691. PubMed ID: 36085578
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
36. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
38. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Dai D; Shi R; Han S; Jin H; Wang X
Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
40. Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Liu Y; Huang F; Chen H; Peng Q; Zhao C; Miao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1044-1052. PubMed ID: 33051417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
